Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | STK10 | O94804 | 1/20 | 0.31 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | MYB | P10242 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20736231 | 0.95 | STK10 (0.34) | CA1CA2SOS1SLC6A4STK10 | |
| SCHEMBL27251033 | 0.94 | CA1 (0.33) | CA1CA2SLC22A12SLC6A4STK10 | |
| SCHEMBL20736826 | 0.93 | — | — | |
| SCHEMBL27251316 | 0.92 | SOS1 (0.36) | SOS1CYP1A2CYP1B1 | |
| SCHEMBL20736357 | 0.91 | SLC6A4 (0.30) | SLC6A4 | |
| SCHEMBL20737648 | 0.90 | PDK2 (0.36) | CA1CA2 | |
| SCHEMBL20736828 | 0.88 | STK10 (0.32) | STK10SLK | |
| SCHEMBL20737931 | 0.88 | SOS1 (0.33) | SOS1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL20736230 | 0.88 | PDK2 (0.30) | CA1CA2 | |
| SCHEMBL20736863 | 0.87 | SOS1 (0.33) | SOS1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11552251-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-10 | — | — | US | disclosed |
| US-20190051835-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11552251-B2 | Organic electroluminescent element and electronic device | L1CAM, ESR1, LEF1 | CA1 2450/4885CA2 2379/4885SLC22A12 1584/4885 |
| US-20190051835-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | L1CAM, ESR1, LEF1 | CA1 2450/4885CA2 2379/4885SLC22A12 1584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.